GNOM vs. THNR ETF Comparison
Comparison of Global X Genomics & Biotechnology ETF (GNOM) to Amplify Weight Loss Drug & Treatment ETF (THNR)
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$9.83
Average Daily Volume
43,119
40
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.Grade (RS Rating)
Last Trade
$23.15
Average Daily Volume
2,584
15
Performance
Period | GNOM | THNR |
---|---|---|
30 Days | -8.90% | -11.31% |
60 Days | -13.16% | -15.54% |
90 Days | -14.89% | -17.09% |
12 Months | -5.98% |
0 Overlapping Holdings
Symbol | Grade | Weight in GNOM | Weight in THNR | Overlap |
---|
GNOM Overweight 40 Positions Relative to THNR
Symbol | Grade | Weight | |
---|---|---|---|
VCYT | B | 4.69% | |
CRSP | D | 4.66% | |
NTRA | A | 4.41% | |
ARWR | D | 4.31% | |
TECH | F | 4.21% | |
ILMN | C | 4.14% | |
QGEN | D | 4.09% | |
RNA | C | 4.06% | |
BEAM | D | 4.03% | |
A | D | 3.93% | |
BNTX | C | 3.83% | |
BMRN | F | 3.71% | |
ALNY | D | 3.71% | |
RARE | F | 3.63% | |
LEGN | D | 3.56% | |
SRPT | F | 3.55% | |
NTLA | F | 3.23% | |
MRNA | F | 3.13% | |
TXG | F | 2.93% | |
MYGN | F | 2.8% | |
RCKT | F | 2.62% | |
GILD | C | 2.17% | |
CDNA | D | 2.13% | |
VRTX | D | 2.09% | |
VIR | D | 1.61% | |
MRVI | F | 1.26% | |
PACB | F | 1.18% | |
SGMO | C | 0.99% | |
RGNX | D | 0.95% | |
ALLO | F | 0.79% | |
VERV | F | 0.74% | |
FLGT | F | 0.73% | |
SANA | F | 0.65% | |
QURE | C | 0.64% | |
EDIT | F | 0.5% | |
PSTX | D | 0.44% | |
CRBU | D | 0.42% | |
TSVT | F | 0.41% | |
LYEL | F | 0.31% | |
SCLX | F | 0.01% |
GNOM: Top Represented Industries & Keywords
THNR: Top Represented Industries & Keywords